Estimation of the impact of warfarin's time-in-therapeutic range on stroke and major bleeding rates and its influence on the medical cost avoidance associated with …

A Amin, S Deitelzweig, Y Jing, D Makenbaeva… - Journal of thrombosis …, 2014 - Springer
Warfarin’s time-in-therapeutic range (TTR) is highly variable among patients with nonvalvular
atrial fibrillation (NVAF). The objective of this study was to estimate the impact of variations …

A systematic review of augmentation strategies for patients with major depressive disorder.

R Fleurence, R Williamson, Y Jing, E Kim… - Psychopharmacology …, 2009 - europepmc.org
Major depressive disorder (MDD) is a leading cause of disability worldwide. Clinicians need
to determine the most appropriate and effective interventions for patients who do not benefit …

[HTML][HTML] Deep phenotyping of 34,128 adult patients hospitalised with COVID-19 in an international network study

…, J Hardin, G Hripcsak, V Huser, H Jeon, Y Jing… - Nature …, 2020 - nature.com
Comorbid conditions appear to be common among individuals hospitalised with coronavirus
disease 2019 (COVID-19) but estimates of prevalence vary and little is known about the …

Clinical outcomes in measurement‐based treatment (comet): A trial of depression monitoring and feedback to primary care physicians

AS Yeung, Y Jing, SK Brenneman… - Depression and …, 2012 - Wiley Online Library
Background Despite the availability of effective treatments for depression, many patients
under the care of primary care physicians do not achieve remission. Clinical Outcomes in …

Medical cost reductions associated with the usage of novel oral anticoagulants vs warfarin among atrial fibrillation patients, based on the RE-LY, ROCKET-AF, and …

S Deitelzweig, A Amin, Y Jing… - Journal of medical …, 2012 - Taylor & Francis
Full article: Medical cost reductions associated with the usage of novel oral anticoagulants
vs warfarin among atrial fibrillation patients, based on the RE-LY, ROCKET-AF, and …

Utilization, price, and spending trends for antidepressants in the US Medicaid Program

Y Chen, CML Kelton, Y Jing, JJ Guo, X Li… - Research in Social and …, 2008 - Elsevier
BACKGROUND: Antidepressants are often used in the treatment of major depressive disorder
and other mental illnesses, and constitute one of the most widely prescribed and costly …

[HTML][HTML] Evaluation of adherence and persistence differences between adalimumab citrate-free and citrate formulations for patients with immune-mediated diseases in …

M Bergman, P Patel, N Chen, Y Jing… - Rheumatology and …, 2021 - Springer
Introduction Our aim was to evaluate patient adherence and persistence with citrate-free
adalimumab (ADA-CF), introduced in 2018 to reduce injection-site pain, compared with citrate-…

Warfarin use and stroke risk among patients with nonvalvular atrial fibrillation in a large managed care population

…, E Buysman, B Pinsky, M Lacey, Y Jing… - Clinical …, 2013 - Elsevier
… Lacey MSc 2 , Yonghua Jing PhD 3 , Daniel Wiederkehr 4 , John Graham PharmD 3 …
Jing and Graham are employees of Bristol-Myers Squibb and own stock in the company. Dr. …

Exposure to potentially dangerous drug-drug interactions involving antipsychotics

JJ Guo, J Wu, CML Kelton, Y Jing, H Fan… - Psychiatric …, 2012 - Am Psychiatric Assoc
Objective Antipsychotic drug therapy is the cornerstone of treatment of persons with
schizophrenia. Because most antipsychotics are metabolized by the hepatic cytochrome P450 …

Deep phenotyping of 34,128 patients hospitalised with COVID-19 and a comparison with 81,596 influenza patients in America, Europe and Asia: an international …

…, J Hardin, G Hripcsak, V Huser, H Jeon, Y Jing… - medRxiv, 2020 - medrxiv.org
Background In this study we phenotyped individuals hospitalised with coronavirus disease
2019 (COVID-19) in depth, summarising entire medical histories, including medications, as …